Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Generic Claims:
advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes…
Red Flags:
FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified…
Semantic Drift Patterns:
homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations:
specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations…
AbbVie Inc.
(https://maviret.com) 📸 Data Snapshot: May 30, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE MAVYRET (glecaprevir/pibrentasvir) for Hepatitis C - Official Site (https://maviret.com)
Title
MAVYRET (glecaprevir/pibrentasvir) for Hepatitis C - Official Site
Meta
Official MAVYRET (glecaprevir/pibrentasvir) site from AbbVie Inc. for patients. Learn about the use, safety and efficacy of MAVYRET. View full prescribing information.
H1 Hep C:ONLY8 WEEKS TO CURE†
H2 You are leaving MAVYRET.com
H2 Are you a healthcare professional?
H2 You are leaving MAVYRET.com
H3 A personal message
from real patients
H3 Meet some of the 1 MILLION treated‡
H3 MAVYRET is covered by most insurance plans
NAV_HEADER_HEADING_REPEATED_BODY_FOOTER MAVYRET (glecaprevir/pibrentasvir) for Hepatitis C - Official Site (https://maviret.com/locator/)
Title
MAVYRET (glecaprevir/pibrentasvir) for Hepatitis C - Official Site
Meta
Official MAVYRET (glecaprevir/pibrentasvir) site from AbbVie Inc. for patients. Learn about the use, safety and efficacy of MAVYRET. View full prescribing information.
H1 Hep C:ONLY8 WEEKS TO CURE†
H2 You are leaving MAVYRET.com
H2 Are you a healthcare professional?
H2 You are leaving MAVYRET.com
H3 A personal message
from real patients
H3 Meet some of the 1 MILLION treated‡
H3 MAVYRET is covered by most insurance plans
NAV_HEADER_HEADING_REPEATED_BODY_FOOTER MAVYRET (glecaprevir/pibrentasvir) for Hepatitis C - Official Site (https://maviret.com/cost/)
Title
MAVYRET (glecaprevir/pibrentasvir) for Hepatitis C - Official Site
Meta
Official MAVYRET (glecaprevir/pibrentasvir) site from AbbVie Inc. for patients. Learn about the use, safety and efficacy of MAVYRET. View full prescribing information.
H1 Hep C:ONLY8 WEEKS TO CURE†
H2 You are leaving MAVYRET.com
H2 Are you a healthcare professional?
H2 You are leaving MAVYRET.com
H3 A personal message
from real patients
H3 Meet some of the 1 MILLION treated‡
H3 MAVYRET is covered by most insurance plans
NAV_HEADER_HEADING_REPEATED_BODY MAVYRET (glecaprevir/pibrentasvir) for Hepatitis C - Official Site (https://maviret.com/what-is-mavyret/)
Title
MAVYRET (glecaprevir/pibrentasvir) for Hepatitis C - Official Site
Meta
Official MAVYRET (glecaprevir/pibrentasvir) site from AbbVie Inc. for patients. Learn about the use, safety and efficacy of MAVYRET. View full prescribing information.
H1 Hep C:ONLY8 WEEKS TO CURE†
H2 You are leaving MAVYRET.com
H2 Are you a healthcare professional?
H2 You are leaving MAVYRET.com
H3 A personal message
from real patients
H3 Meet some of the 1 MILLION treated‡
H3 MAVYRET is covered by most insurance plans
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://maviret.com) MAVYRET (glecaprevir/pibrentasvir) for Hepatitis C - Official Site
In this page special characters are used as Footnotes reference and respective footnotes are present at the end of the main landmark #1 prescribed medicine for hep C* [H1] Hep C:ONLY8 WEEKS TO CURE† For those new to treatment. Why MAVYRET *Based on data from IQVIA, week ending 1/12/18 to 2/28/2025. †Cure means no hep C virus found in the blood 3 months after treatment ends. Individual results may vary. MAVYRET is a prescription medicine used to treat adults and children 3 years of age and older with acute (recently infected) or chronic (lasting a long time) hepatitis C virus (hep C) genotypes 1, 2, 3, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis. Find a healthcare professional or clinic near you. Ask about the only 8-week cure for all types of hep C. Use our locator tool [H3] A personal message from real patients [H3] Transcript View Transcript [H3] Meet some of the 1 MILLION treated‡ Explore real stories of cure [H3] MAVYRET is covered by most insurance plans See how you can save ‡Based on Global AbbVie sales estimates 7/26/2017-10/31/2023. USE MAVYRET is a prescription medicine used to treat adults and children 3 years of age and older with: Acute (recently infected) or chronic (lasting a long time) hepatitis C virus (hep C) genotypes 1, 2, 3, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis. Hep C genotype 1 infection who have been previously treated with a regimen that contained a hep C NS5A inhibitor or an NS3/4A protease inhibitor, but not both. IMPORTANT SAFETY INFORMATION What is the most important information I should know about MAVYRET? Hepatitis B virus (hep B) reactivation: Before starting treatment with MAVYRET, your doctor will do blood tests to check for hep B infection. If you have ever had hep B infection, hep B could become active again during or after treatment for hep C with MAVYRET. Hep B that becomes active again (called reactivation) may cause serious liver problems, including liver failure and death. Your doctor will monitor you if you are at risk for hep B reactivation during treatment and after you stop taking MAVYRET. Do not take MAVYRET if you: Have moderate or severe liver impairment (Child-Pugh B or C) or any history of prior liver decompensation Are taking the medicines atazanavir or rifampin What should I tell my doctor before taking MAVYRET? If you have had hep B infection, have liver problems other than hep C infection, have HIV-1 infection, have had a liver or a kidney transplant, and all other medical conditions. If you are pregnant or plan to become pregnant, or if you are breastfeeding or plan to breastfeed. It is not known if MAVYRET will harm your unborn baby or pass into your breast milk. Talk to your doctor about the best way to feed your baby if you take MAVYRET. About all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. MAVYRET and other medicines may affect each other. This can cause you to have too much or not enough MAVYRET or other medicines in your body. This may affect the way MAVYRET or your other medicines work or may cause side effects. Do not start taking a new medicine without telling your doctor. Your doctor can tell you if it is safe to take MAVYRET with other medicines. What are the possible side effects of MAVYRET? In people who had or have advanced liver problems before starting treatment with MAVYRET, there is a rare risk of worsening liver problems, liver failure, and death. Your doctor will check you for signs and symptoms of worsening liver problems during treatment with MAVYRET. Tell your doctor right away if you have any of the following: nausea; tiredness; yellowing of your skin or white part of your eyes; bleeding or bruising more easily than normal; confusion; dark, black, or bloody stool; loss of appetite; diarrhea; dark or brown (tea-colored) urine; swelling or pain on the upper right side of your stomach area (abdomen); sleepiness; vomiting of blood; or lightheadedness. The most common side effects of MAVYRET are headache and tiredness. These are not all the possible side effects of MAVYRET. Call your doctor for medical advice about side effects. This is the most important information to know about MAVYRET. For more information, talk to your doctor or healthcare provider. MAVYRET oral pellets are dispensed in unit-dose packets. Each packet contains 50 mg glecaprevir/20 mg pibrentasvir. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please see full Prescribing Information, including the Patient Information. If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more. US-MAVY-250259 [H2] You are leaving MAVYRET.com You are leaving the AbbVie website and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility. Conversely, the presence of this link does not imply the linked site's endorsement of MAVYRET.com or AbbVie. Do you wish to leave this site? Yes No US-MAVY-220333 USE MAVYRET is a prescription medicine used to treat adults and children 3 years of age and older with: Acute (recently infected) or chronic (lasting a long time) hepatitis C virus (hep C) genotypes 1, 2, 3, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis. Hep C genotype 1 infection who have been previously treated with a regimen that contained a hep C NS5A inhibitor or an NS3/4A protease inhibitor, but not both. IMPORTANT SAFETY INFORMATION What is the most important information I should know about MAVYRET? Hepatitis B virus (hep B) reactivation: Before starting treatment with MAVYRET, your doctor will do blood tests to check for hep B infection. If you have ever had hep B infection, hep B could become active again during or after treatment for hep C with MAVYRET. Hep B that becomes active again (called reactivation) may cause serious liver problems, including liver failure and death. Your doctor will monitor you if you are at risk for hep B reactivation during treatment and after you stop taking MAVYRET. Do not take MAVYRET if you: Have moderate or severe liver impairment (Child-Pugh B or C) or any history of prior liver decompensation Are taking the medicines atazanavir or rifampin What should I tell my doctor before taking MAVYRET? If you have had hep B infection, have liver problems other than hep C infection, have HIV-1 infection, have had a liver or a kidney transplant, and all other medical conditions. If you are pregnant or plan to become pregnant, or if you are breastfeeding or plan to breastfeed. It is not known if MAVYRET will harm your unborn baby or pass into your breast milk. Talk to your doctor about the best way to feed your baby if you take MAVYRET. About all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. MAVYRET and other medicines may affect each other. This can cause you to have too much or not enough MAVYRET or other medicines in your body. This may affect the way MAVYRET or your other medicines work or may cause side effects. Do not start taking a new medicine without telling your doctor. Your doctor can tell you if it is safe to take MAVYRET with other medicines. What are the possible side effects of MAVYRET? In people who had or have advanced liver problems before starting treatment with MAVYRET, there is a rare risk of worsening liver problems, liver failure, and death. Your doctor will check you for signs and symptoms of worsening liver problems during treatment with MAVYRET. Tell your doctor right away if you have any of the following: nausea; tiredness; yellowing of your skin or white part of your eyes; bleeding or bruising more easily than normal; confusion; dark, black, or bloody stool; loss of appetite; diarrhea; dark or brown (tea-colored) urine; swelling or pain on the upper right side of your stomach area (abdomen); sleepiness; vomiting of blood; or lightheadedness. The most common side effects of MAVYRET are headache and tiredness. These are not all the possible side effects of MAVYRET. Call your doctor for medical advice about side effects. This is the most important information to know about MAVYRET. For more information, talk to your doctor or healthcare provider. MAVYRET oral pellets are dispensed in unit-dose packets. Each packet contains 50 mg glecaprevir/20 mg pibrentasvir. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please see full Prescribing Information, including the Patient Information. If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more. US-MAVY-250259 US-MAVY-240176 [H2] Are you a healthcare professional? The information contained in this site is intended for U.S. healthcare professionals. By clicking “Yes” below, you certify that you are a licensed healthcare professional. Yes No US-MAVY-240223 [H2] You are leaving MAVYRET.com You are leaving the AbbVie website and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility. Conversely, the presence of this link does not imply the linked site's endorsement of MAVYRET.com or AbbVie. Do you wish to leave this site? Yes No US-MAVY-240223 Important Safety Information about MAVYRET including Important Warning on Hepatitis B Reactivation Important Safety Information about MAVYRET including Important Warning on Hepatitis B Reactivation Important Safety Information about MAVYRET including Important Warning on Hepatitis B Reactivation Important Safety Information about MAVYRET including Important Warning on Hepatitis B Reactivation USE MAVYRET is a prescription medicine used to treat adults and children 3 years of age and older with: Acute (recently infected) or chronic (lasting a long time) hepatitis C virus (hep C) genotypes 1, 2, 3, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis. Hep C genotype 1 infection who have been previously treated with a regimen that contained a hep C NS5A inhibitor or an NS3/4A protease inhibitor, but not both. IMPORTANT SAFETY INFORMATION What is the most important information I should know about MAVYRET? Hepatitis B virus (hep B) reactivation: Before starting treatment with MAVYRET, your doctor will do blood tests to check for hep B infection. If you have ever had hep B infection, hep B could become active again during or after treatment for hep C with MAVYRET. Hep B that becomes active again (called reactivation) may cause serious liver problems, including liver failure and death. Your doctor will monitor you if you are at risk for hep B reactivation during treatment and after you stop taking MAVYRET. Do not take MAVYRET if you: Have moderate or severe liver impairment (Child-Pugh B or C) or any history of prior liver decompensation Are taking the medicines atazanavir or rifampin What should I tell my doctor before taking MAVYRET? If you have had hep B infection, have liver problems other than hep C infection, have HIV-1 infection, have had a liver or a kidney transplant, and all other medical conditions. If you are pregnant or plan to become pregnant, or if you are breastfeeding or plan to breastfeed. It is not known if MAVYRET will harm your unborn baby or pass into your breast milk. Talk to your doctor about the best way to feed your baby if you take MAVYRET. About all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. MAVYRET and other medicines may affect each other. This can cause you to have too much or not enough MAVYRET or other medicines in your body. This may affect the way MAVYRET or your other medicines work or may cause side effects. Do not start taking a new medicine without telling your doctor. Your doctor can tell you if it is safe to take MAVYRET with other medicines. What are the possible side effects of MAVYRET? In people who had or have advanced liver problems before starting treatment with MAVYRET, there is a rare risk of worsening liver problems, liver failure, and death. Your doctor will check you for signs and symptoms of worsening liver problems during treatment with MAVYRET. Tell your doctor right away if you have any of the following: nausea; tiredness; yellowing of your skin or white part of your eyes; bleeding or bruising more easily than normal; confusion; dark, black, or bloody stool; loss of appetite; diarrhea; dark or brown (tea-colored) urine; swelling or pain on the upper right side of your stomach area (abdomen); sleepiness; vomiting of blood; or lightheadedness. The most common side effects of MAVYRET are headache and tiredness. These are not all the possible side effects of MAVYRET. Call your doctor for medical advice about side effects. This is the most important information to know about MAVYRET. For more information, talk to your doctor or healthcare provider. MAVYRET oral pellets are dispensed in unit-dose packets. Each pac
15000 chars
SUB-PAGE (https://maviret.com/locator/) MAVYRET (glecaprevir/pibrentasvir) for Hepatitis C - Official Site
In this page special characters are used as Footnotes reference and respective footnotes are present at the end of the main landmark #1 prescribed medicine for hep C* [H1] Hep C:ONLY8 WEEKS TO CURE† For those new to treatment. Why MAVYRET *Based on data from IQVIA, week ending 1/12/18 to 2/28/2025. †Cure means no hep C virus found in the blood 3 months after treatment ends. Individual results may vary. MAVYRET is a prescription medicine used to treat adults and children 3 years of age and older with acute (recently infected) or chronic (lasting a long time) hepatitis C virus (hep C) genotypes 1, 2, 3, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis. Find a healthcare professional or clinic near you. Ask about the only 8-week cure for all types of hep C. Use our locator tool [H3] A personal message from real patients [H3] Transcript View Transcript [H3] Meet some of the 1 MILLION treated‡ Explore real stories of cure [H3] MAVYRET is covered by most insurance plans See how you can save ‡Based on Global AbbVie sales estimates 7/26/2017-10/31/2023. USE MAVYRET is a prescription medicine used to treat adults and children 3 years of age and older with: Acute (recently infected) or chronic (lasting a long time) hepatitis C virus (hep C) genotypes 1, 2, 3, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis. Hep C genotype 1 infection who have been previously treated with a regimen that contained a hep C NS5A inhibitor or an NS3/4A protease inhibitor, but not both. IMPORTANT SAFETY INFORMATION What is the most important information I should know about MAVYRET? Hepatitis B virus (hep B) reactivation: Before starting treatment with MAVYRET, your doctor will do blood tests to check for hep B infection. If you have ever had hep B infection, hep B could become active again during or after treatment for hep C with MAVYRET. Hep B that becomes active again (called reactivation) may cause serious liver problems, including liver failure and death. Your doctor will monitor you if you are at risk for hep B reactivation during treatment and after you stop taking MAVYRET. Do not take MAVYRET if you: Have moderate or severe liver impairment (Child-Pugh B or C) or any history of prior liver decompensation Are taking the medicines atazanavir or rifampin What should I tell my doctor before taking MAVYRET? If you have had hep B infection, have liver problems other than hep C infection, have HIV-1 infection, have had a liver or a kidney transplant, and all other medical conditions. If you are pregnant or plan to become pregnant, or if you are breastfeeding or plan to breastfeed. It is not known if MAVYRET will harm your unborn baby or pass into your breast milk. Talk to your doctor about the best way to feed your baby if you take MAVYRET. About all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. MAVYRET and other medicines may affect each other. This can cause you to have too much or not enough MAVYRET or other medicines in your body. This may affect the way MAVYRET or your other medicines work or may cause side effects. Do not start taking a new medicine without telling your doctor. Your doctor can tell you if it is safe to take MAVYRET with other medicines. What are the possible side effects of MAVYRET? In people who had or have advanced liver problems before starting treatment with MAVYRET, there is a rare risk of worsening liver problems, liver failure, and death. Your doctor will check you for signs and symptoms of worsening liver problems during treatment with MAVYRET. Tell your doctor right away if you have any of the following: nausea; tiredness; yellowing of your skin or white part of your eyes; bleeding or bruising more easily than normal; confusion; dark, black, or bloody stool; loss of appetite; diarrhea; dark or brown (tea-colored) urine; swelling or pain on the upper right side of your stomach area (abdomen); sleepiness; vomiting of blood; or lightheadedness. The most common side effects of MAVYRET are headache and tiredness. These are not all the possible side effects of MAVYRET. Call your doctor for medical advice about side effects. This is the most important information to know about MAVYRET. For more information, talk to your doctor or healthcare provider. MAVYRET oral pellets are dispensed in unit-dose packets. Each packet contains 50 mg glecaprevir/20 mg pibrentasvir. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please see full Prescribing Information, including the Patient Information. If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more. US-MAVY-250259 [H2] You are leaving MAVYRET.com You are leaving the AbbVie website and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility. Conversely, the presence of this link does not imply the linked site's endorsement of MAVYRET.com or AbbVie. Do you wish to leave this site? Yes No US-MAVY-220333 USE MAVYRET is a prescription medicine used to treat adults and children 3 years of age and older with: Acute (recently infected) or chronic (lasting a long time) hepatitis C virus (hep C) genotypes 1, 2, 3, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis. Hep C genotype 1 infection who have been previously treated with a regimen that contained a hep C NS5A inhibitor or an NS3/4A protease inhibitor, but not both. IMPORTANT SAFETY INFORMATION What is the most important information I should know about MAVYRET? Hepatitis B virus (hep B) reactivation: Before starting treatment with MAVYRET, your doctor will do blood tests to check for hep B infection. If you have ever had hep B infection, hep B could become active again during or after treatment for hep C with MAVYRET. Hep B that becomes active again (called reactivation) may cause serious liver problems, including liver failure and death. Your doctor will monitor you if you are at risk for hep B reactivation during treatment and after you stop taking MAVYRET. Do not take MAVYRET if you: Have moderate or severe liver impairment (Child-Pugh B or C) or any history of prior liver decompensation Are taking the medicines atazanavir or rifampin What should I tell my doctor before taking MAVYRET? If you have had hep B infection, have liver problems other than hep C infection, have HIV-1 infection, have had a liver or a kidney transplant, and all other medical conditions. If you are pregnant or plan to become pregnant, or if you are breastfeeding or plan to breastfeed. It is not known if MAVYRET will harm your unborn baby or pass into your breast milk. Talk to your doctor about the best way to feed your baby if you take MAVYRET. About all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. MAVYRET and other medicines may affect each other. This can cause you to have too much or not enough MAVYRET or other medicines in your body. This may affect the way MAVYRET or your other medicines work or may cause side effects. Do not start taking a new medicine without telling your doctor. Your doctor can tell you if it is safe to take MAVYRET with other medicines. What are the possible side effects of MAVYRET? In people who had or have advanced liver problems before starting treatment with MAVYRET, there is a rare risk of worsening liver problems, liver failure, and death. Your doctor will check you for signs and symptoms of worsening liver problems during treatment with MAVYRET. Tell your doctor right away if you have any of the following: nausea; tiredness; yellowing of your skin or white part of your eyes; bleeding or bruising more easily than normal; confusion; dark, black, or bloody stool; loss of appetite; diarrhea; dark or brown (tea-colored) urine; swelling or pain on the upper right side of your stomach area (abdomen); sleepiness; vomiting of blood; or lightheadedness. The most common side effects of MAVYRET are headache and tiredness. These are not all the possible side effects of MAVYRET. Call your doctor for medical advice about side effects. This is the most important information to know about MAVYRET. For more information, talk to your doctor or healthcare provider. MAVYRET oral pellets are dispensed in unit-dose packets. Each packet contains 50 mg glecaprevir/20 mg pibrentasvir. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please see full Prescribing Information, including the Patient Information. If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more. US-MAVY-250259 US-MAVY-240176 [H2] Are you a healthcare professional? The information contained in this site is intended for U.S. healthcare professionals. By clicking “Yes” below, you certify that you are a licensed healthcare professional. Yes No US-MAVY-240223 [H2] You are leaving MAVYRET.com You are leaving the AbbVie website and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility. Conversely, the presence of this link does not imply the linked site's endorsement of MAVYRET.com or AbbVie. Do you wish to leave this site? Yes No US-MAVY-240223 Important Safety Information about MAVYRET including Important Warning on Hepatitis B Reactivation Important Safety Information about MAVYRET including Important Warning on Hepatitis B Reactivation Important Safety Information about MAVYRET including Important Warning on Hepatitis B Reactivation Important Safety Information about MAVYRET including Important Warning on Hepatitis B Reactivation USE MAVYRET is a prescription medicine used to treat adults and children 3 years of age and older with: Acute (recently infected) or chronic (lasting a long time) hepatitis C virus (hep C) genotypes 1, 2, 3, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis. Hep C genotype 1 infection who have been previously treated with a regimen that contained a hep C NS5A inhibitor or an NS3/4A protease inhibitor, but not both. IMPORTANT SAFETY INFORMATION What is the most important information I should know about MAVYRET? Hepatitis B virus (hep B) reactivation: Before starting treatment with MAVYRET, your doctor will do blood tests to check for hep B infection. If you have ever had hep B infection, hep B could become active again during or after treatment for hep C with MAVYRET. Hep B that becomes active again (called reactivation) may cause serious liver problems, including liver failure and death. Your doctor will monitor you if you are at risk for hep B reactivation during treatment and after you stop taking MAVYRET. Do not take MAVYRET if you: Have moderate or severe liver impairment (Child-Pugh B or C) or any history of prior liver decompensation Are taking the medicines atazanavir or rifampin What should I tell my doctor before taking MAVYRET? If you have had hep B infection, have liver problems other than hep C infection, have HIV-1 infection, have had a liver or a kidney transplant, and all other medical conditions. If you are pregnant or plan to become pregnant, or if you are breastfeeding or plan to breastfeed. It is not known if MAVYRET will harm your unborn baby or pass into your breast milk. Talk to your doctor about the best way to feed your baby if you take MAVYRET. About all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. MAVYRET and other medicines may affect each other. This can cause you to have too much or not enough MAVYRET or other medicines in your body. This may affect the way MAVYRET or your other medicines work or may cause side effects. Do not start taking a new medicine without telling your doctor. Your doctor can tell you if it is safe to take MAVYRET with other medicines. What are the possible side effects of MAVYRET? In people who had or have advanced liver problems before starting treatment with MAVYRET, there is a rare risk of worsening liver problems, liver failure, and death. Your doctor will check you for signs and symptoms of worsening liver problems during treatment with MAVYRET. Tell your doctor right away if you have any of the following: nausea; tiredness; yellowing of your skin or white part of your eyes; bleeding or bruising more easily than normal; confusion; dark, black, or bloody stool; loss of appetite; diarrhea; dark or brown (tea-colored) urine; swelling or pain on the upper right side of your stomach area (abdomen); sleepiness; vomiting of blood; or lightheadedness. The most common side effects of MAVYRET are headache and tiredness. These are not all the possible side effects of MAVYRET. Call your doctor for medical advice about side effects. This is the most important information to know about MAVYRET. For more information, talk to your doctor or healthcare provider. MAVYRET oral pellets are dispensed in unit-dose packets. Each pac
15000 chars
SUB-PAGE (https://maviret.com/cost/) MAVYRET (glecaprevir/pibrentasvir) for Hepatitis C - Official Site
In this page special characters are used as Footnotes reference and respective footnotes are present at the end of the main landmark #1 prescribed medicine for hep C* [H1] Hep C:ONLY8 WEEKS TO CURE† For those new to treatment. Why MAVYRET *Based on data from IQVIA, week ending 1/12/18 to 2/28/2025. †Cure means no hep C virus found in the blood 3 months after treatment ends. Individual results may vary. MAVYRET is a prescription medicine used to treat adults and children 3 years of age and older with acute (recently infected) or chronic (lasting a long time) hepatitis C virus (hep C) genotypes 1, 2, 3, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis. Find a healthcare professional or clinic near you. Ask about the only 8-week cure for all types of hep C. Use our locator tool [H3] A personal message from real patients [H3] Transcript View Transcript [H3] Meet some of the 1 MILLION treated‡ Explore real stories of cure [H3] MAVYRET is covered by most insurance plans See how you can save ‡Based on Global AbbVie sales estimates 7/26/2017-10/31/2023. USE MAVYRET is a prescription medicine used to treat adults and children 3 years of age and older with: Acute (recently infected) or chronic (lasting a long time) hepatitis C virus (hep C) genotypes 1, 2, 3, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis. Hep C genotype 1 infection who have been previously treated with a regimen that contained a hep C NS5A inhibitor or an NS3/4A protease inhibitor, but not both. IMPORTANT SAFETY INFORMATION What is the most important information I should know about MAVYRET? Hepatitis B virus (hep B) reactivation: Before starting treatment with MAVYRET, your doctor will do blood tests to check for hep B infection. If you have ever had hep B infection, hep B could become active again during or after treatment for hep C with MAVYRET. Hep B that becomes active again (called reactivation) may cause serious liver problems, including liver failure and death. Your doctor will monitor you if you are at risk for hep B reactivation during treatment and after you stop taking MAVYRET. Do not take MAVYRET if you: Have moderate or severe liver impairment (Child-Pugh B or C) or any history of prior liver decompensation Are taking the medicines atazanavir or rifampin What should I tell my doctor before taking MAVYRET? If you have had hep B infection, have liver problems other than hep C infection, have HIV-1 infection, have had a liver or a kidney transplant, and all other medical conditions. If you are pregnant or plan to become pregnant, or if you are breastfeeding or plan to breastfeed. It is not known if MAVYRET will harm your unborn baby or pass into your breast milk. Talk to your doctor about the best way to feed your baby if you take MAVYRET. About all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. MAVYRET and other medicines may affect each other. This can cause you to have too much or not enough MAVYRET or other medicines in your body. This may affect the way MAVYRET or your other medicines work or may cause side effects. Do not start taking a new medicine without telling your doctor. Your doctor can tell you if it is safe to take MAVYRET with other medicines. What are the possible side effects of MAVYRET? In people who had or have advanced liver problems before starting treatment with MAVYRET, there is a rare risk of worsening liver problems, liver failure, and death. Your doctor will check you for signs and symptoms of worsening liver problems during treatment with MAVYRET. Tell your doctor right away if you have any of the following: nausea; tiredness; yellowing of your skin or white part of your eyes; bleeding or bruising more easily than normal; confusion; dark, black, or bloody stool; loss of appetite; diarrhea; dark or brown (tea-colored) urine; swelling or pain on the upper right side of your stomach area (abdomen); sleepiness; vomiting of blood; or lightheadedness. The most common side effects of MAVYRET are headache and tiredness. These are not all the possible side effects of MAVYRET. Call your doctor for medical advice about side effects. This is the most important information to know about MAVYRET. For more information, talk to your doctor or healthcare provider. MAVYRET oral pellets are dispensed in unit-dose packets. Each packet contains 50 mg glecaprevir/20 mg pibrentasvir. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please see full Prescribing Information, including the Patient Information. If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more. US-MAVY-250259 [H2] You are leaving MAVYRET.com You are leaving the AbbVie website and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility. Conversely, the presence of this link does not imply the linked site's endorsement of MAVYRET.com or AbbVie. Do you wish to leave this site? Yes No US-MAVY-220333 USE MAVYRET is a prescription medicine used to treat adults and children 3 years of age and older with: Acute (recently infected) or chronic (lasting a long time) hepatitis C virus (hep C) genotypes 1, 2, 3, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis. Hep C genotype 1 infection who have been previously treated with a regimen that contained a hep C NS5A inhibitor or an NS3/4A protease inhibitor, but not both. IMPORTANT SAFETY INFORMATION What is the most important information I should know about MAVYRET? Hepatitis B virus (hep B) reactivation: Before starting treatment with MAVYRET, your doctor will do blood tests to check for hep B infection. If you have ever had hep B infection, hep B could become active again during or after treatment for hep C with MAVYRET. Hep B that becomes active again (called reactivation) may cause serious liver problems, including liver failure and death. Your doctor will monitor you if you are at risk for hep B reactivation during treatment and after you stop taking MAVYRET. Do not take MAVYRET if you: Have moderate or severe liver impairment (Child-Pugh B or C) or any history of prior liver decompensation Are taking the medicines atazanavir or rifampin What should I tell my doctor before taking MAVYRET? If you have had hep B infection, have liver problems other than hep C infection, have HIV-1 infection, have had a liver or a kidney transplant, and all other medical conditions. If you are pregnant or plan to become pregnant, or if you are breastfeeding or plan to breastfeed. It is not known if MAVYRET will harm your unborn baby or pass into your breast milk. Talk to your doctor about the best way to feed your baby if you take MAVYRET. About all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. MAVYRET and other medicines may affect each other. This can cause you to have too much or not enough MAVYRET or other medicines in your body. This may affect the way MAVYRET or your other medicines work or may cause side effects. Do not start taking a new medicine without telling your doctor. Your doctor can tell you if it is safe to take MAVYRET with other medicines. What are the possible side effects of MAVYRET? In people who had or have advanced liver problems before starting treatment with MAVYRET, there is a rare risk of worsening liver problems, liver failure, and death. Your doctor will check you for signs and symptoms of worsening liver problems during treatment with MAVYRET. Tell your doctor right away if you have any of the following: nausea; tiredness; yellowing of your skin or white part of your eyes; bleeding or bruising more easily than normal; confusion; dark, black, or bloody stool; loss of appetite; diarrhea; dark or brown (tea-colored) urine; swelling or pain on the upper right side of your stomach area (abdomen); sleepiness; vomiting of blood; or lightheadedness. The most common side effects of MAVYRET are headache and tiredness. These are not all the possible side effects of MAVYRET. Call your doctor for medical advice about side effects. This is the most important information to know about MAVYRET. For more information, talk to your doctor or healthcare provider. MAVYRET oral pellets are dispensed in unit-dose packets. Each packet contains 50 mg glecaprevir/20 mg pibrentasvir. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please see full Prescribing Information, including the Patient Information. If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more. US-MAVY-250259 US-MAVY-240176 [H2] Are you a healthcare professional? The information contained in this site is intended for U.S. healthcare professionals. By clicking “Yes” below, you certify that you are a licensed healthcare professional. Yes No US-MAVY-240223 [H2] You are leaving MAVYRET.com You are leaving the AbbVie website and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility. Conversely, the presence of this link does not imply the linked site's endorsement of MAVYRET.com or AbbVie. Do you wish to leave this site? Yes No US-MAVY-240223 Important Safety Information about MAVYRET including Important Warning on Hepatitis B Reactivation Important Safety Information about MAVYRET including Important Warning on Hepatitis B Reactivation Important Safety Information about MAVYRET including Important Warning on Hepatitis B Reactivation Important Safety Information about MAVYRET including Important Warning on Hepatitis B Reactivation USE MAVYRET is a prescription medicine used to treat adults and children 3 years of age and older with: Acute (recently infected) or chronic (lasting a long time) hepatitis C virus (hep C) genotypes 1, 2, 3, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis. Hep C genotype 1 infection who have been previously treated with a regimen that contained a hep C NS5A inhibitor or an NS3/4A protease inhibitor, but not both. IMPORTANT SAFETY INFORMATION What is the most important information I should know about MAVYRET? Hepatitis B virus (hep B) reactivation: Before starting treatment with MAVYRET, your doctor will do blood tests to check for hep B infection. If you have ever had hep B infection, hep B could become active again during or after treatment for hep C with MAVYRET. Hep B that becomes active again (called reactivation) may cause serious liver problems, including liver failure and death. Your doctor will monitor you if you are at risk for hep B reactivation during treatment and after you stop taking MAVYRET. Do not take MAVYRET if you: Have moderate or severe liver impairment (Child-Pugh B or C) or any history of prior liver decompensation Are taking the medicines atazanavir or rifampin What should I tell my doctor before taking MAVYRET? If you have had hep B infection, have liver problems other than hep C infection, have HIV-1 infection, have had a liver or a kidney transplant, and all other medical conditions. If you are pregnant or plan to become pregnant, or if you are breastfeeding or plan to breastfeed. It is not known if MAVYRET will harm your unborn baby or pass into your breast milk. Talk to your doctor about the best way to feed your baby if you take MAVYRET. About all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. MAVYRET and other medicines may affect each other. This can cause you to have too much or not enough MAVYRET or other medicines in your body. This may affect the way MAVYRET or your other medicines work or may cause side effects. Do not start taking a new medicine without telling your doctor. Your doctor can tell you if it is safe to take MAVYRET with other medicines. What are the possible side effects of MAVYRET? In people who had or have advanced liver problems before starting treatment with MAVYRET, there is a rare risk of worsening liver problems, liver failure, and death. Your doctor will check you for signs and symptoms of worsening liver problems during treatment with MAVYRET. Tell your doctor right away if you have any of the following: nausea; tiredness; yellowing of your skin or white part of your eyes; bleeding or bruising more easily than normal; confusion; dark, black, or bloody stool; loss of appetite; diarrhea; dark or brown (tea-colored) urine; swelling or pain on the upper right side of your stomach area (abdomen); sleepiness; vomiting of blood; or lightheadedness. The most common side effects of MAVYRET are headache and tiredness. These are not all the possible side effects of MAVYRET. Call your doctor for medical advice about side effects. This is the most important information to know about MAVYRET. For more information, talk to your doctor or healthcare provider. MAVYRET oral pellets are dispensed in unit-dose packets. Each pac
15000 chars
SUB-PAGE (https://maviret.com/what-is-mavyret/) MAVYRET (glecaprevir/pibrentasvir) for Hepatitis C - Official Site
In this page special characters are used as Footnotes reference and respective footnotes are present at the end of the main landmark #1 prescribed medicine for hep C* [H1] Hep C:ONLY8 WEEKS TO CURE† For those new to treatment. Why MAVYRET *Based on data from IQVIA, week ending 1/12/18 to 2/28/2025. †Cure means no hep C virus found in the blood 3 months after treatment ends. Individual results may vary. MAVYRET is a prescription medicine used to treat adults and children 3 years of age and older with acute (recently infected) or chronic (lasting a long time) hepatitis C virus (hep C) genotypes 1, 2, 3, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis. Find a healthcare professional or clinic near you. Ask about the only 8-week cure for all types of hep C. Use our locator tool [H3] A personal message from real patients [H3] Transcript View Transcript [H3] Meet some of the 1 MILLION treated‡ Explore real stories of cure [H3] MAVYRET is covered by most insurance plans See how you can save ‡Based on Global AbbVie sales estimates 7/26/2017-10/31/2023. USE MAVYRET is a prescription medicine used to treat adults and children 3 years of age and older with: Acute (recently infected) or chronic (lasting a long time) hepatitis C virus (hep C) genotypes 1, 2, 3, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis. Hep C genotype 1 infection who have been previously treated with a regimen that contained a hep C NS5A inhibitor or an NS3/4A protease inhibitor, but not both. IMPORTANT SAFETY INFORMATION What is the most important information I should know about MAVYRET? Hepatitis B virus (hep B) reactivation: Before starting treatment with MAVYRET, your doctor will do blood tests to check for hep B infection. If you have ever had hep B infection, hep B could become active again during or after treatment for hep C with MAVYRET. Hep B that becomes active again (called reactivation) may cause serious liver problems, including liver failure and death. Your doctor will monitor you if you are at risk for hep B reactivation during treatment and after you stop taking MAVYRET. Do not take MAVYRET if you: Have moderate or severe liver impairment (Child-Pugh B or C) or any history of prior liver decompensation Are taking the medicines atazanavir or rifampin What should I tell my doctor before taking MAVYRET? If you have had hep B infection, have liver problems other than hep C infection, have HIV-1 infection, have had a liver or a kidney transplant, and all other medical conditions. If you are pregnant or plan to become pregnant, or if you are breastfeeding or plan to breastfeed. It is not known if MAVYRET will harm your unborn baby or pass into your breast milk. Talk to your doctor about the best way to feed your baby if you take MAVYRET. About all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. MAVYRET and other medicines may affect each other. This can cause you to have too much or not enough MAVYRET or other medicines in your body. This may affect the way MAVYRET or your other medicines work or may cause side effects. Do not start taking a new medicine without telling your doctor. Your doctor can tell you if it is safe to take MAVYRET with other medicines. What are the possible side effects of MAVYRET? In people who had or have advanced liver problems before starting treatment with MAVYRET, there is a rare risk of worsening liver problems, liver failure, and death. Your doctor will check you for signs and symptoms of worsening liver problems during treatment with MAVYRET. Tell your doctor right away if you have any of the following: nausea; tiredness; yellowing of your skin or white part of your eyes; bleeding or bruising more easily than normal; confusion; dark, black, or bloody stool; loss of appetite; diarrhea; dark or brown (tea-colored) urine; swelling or pain on the upper right side of your stomach area (abdomen); sleepiness; vomiting of blood; or lightheadedness. The most common side effects of MAVYRET are headache and tiredness. These are not all the possible side effects of MAVYRET. Call your doctor for medical advice about side effects. This is the most important information to know about MAVYRET. For more information, talk to your doctor or healthcare provider. MAVYRET oral pellets are dispensed in unit-dose packets. Each packet contains 50 mg glecaprevir/20 mg pibrentasvir. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please see full Prescribing Information, including the Patient Information. If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more. US-MAVY-250259 [H2] You are leaving MAVYRET.com You are leaving the AbbVie website and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility. Conversely, the presence of this link does not imply the linked site's endorsement of MAVYRET.com or AbbVie. Do you wish to leave this site? Yes No US-MAVY-220333 USE MAVYRET is a prescription medicine used to treat adults and children 3 years of age and older with: Acute (recently infected) or chronic (lasting a long time) hepatitis C virus (hep C) genotypes 1, 2, 3, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis. Hep C genotype 1 infection who have been previously treated with a regimen that contained a hep C NS5A inhibitor or an NS3/4A protease inhibitor, but not both. IMPORTANT SAFETY INFORMATION What is the most important information I should know about MAVYRET? Hepatitis B virus (hep B) reactivation: Before starting treatment with MAVYRET, your doctor will do blood tests to check for hep B infection. If you have ever had hep B infection, hep B could become active again during or after treatment for hep C with MAVYRET. Hep B that becomes active again (called reactivation) may cause serious liver problems, including liver failure and death. Your doctor will monitor you if you are at risk for hep B reactivation during treatment and after you stop taking MAVYRET. Do not take MAVYRET if you: Have moderate or severe liver impairment (Child-Pugh B or C) or any history of prior liver decompensation Are taking the medicines atazanavir or rifampin What should I tell my doctor before taking MAVYRET? If you have had hep B infection, have liver problems other than hep C infection, have HIV-1 infection, have had a liver or a kidney transplant, and all other medical conditions. If you are pregnant or plan to become pregnant, or if you are breastfeeding or plan to breastfeed. It is not known if MAVYRET will harm your unborn baby or pass into your breast milk. Talk to your doctor about the best way to feed your baby if you take MAVYRET. About all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. MAVYRET and other medicines may affect each other. This can cause you to have too much or not enough MAVYRET or other medicines in your body. This may affect the way MAVYRET or your other medicines work or may cause side effects. Do not start taking a new medicine without telling your doctor. Your doctor can tell you if it is safe to take MAVYRET with other medicines. What are the possible side effects of MAVYRET? In people who had or have advanced liver problems before starting treatment with MAVYRET, there is a rare risk of worsening liver problems, liver failure, and death. Your doctor will check you for signs and symptoms of worsening liver problems during treatment with MAVYRET. Tell your doctor right away if you have any of the following: nausea; tiredness; yellowing of your skin or white part of your eyes; bleeding or bruising more easily than normal; confusion; dark, black, or bloody stool; loss of appetite; diarrhea; dark or brown (tea-colored) urine; swelling or pain on the upper right side of your stomach area (abdomen); sleepiness; vomiting of blood; or lightheadedness. The most common side effects of MAVYRET are headache and tiredness. These are not all the possible side effects of MAVYRET. Call your doctor for medical advice about side effects. This is the most important information to know about MAVYRET. For more information, talk to your doctor or healthcare provider. MAVYRET oral pellets are dispensed in unit-dose packets. Each packet contains 50 mg glecaprevir/20 mg pibrentasvir. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please see full Prescribing Information, including the Patient Information. If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more. US-MAVY-250259 US-MAVY-240176 [H2] Are you a healthcare professional? The information contained in this site is intended for U.S. healthcare professionals. By clicking “Yes” below, you certify that you are a licensed healthcare professional. Yes No US-MAVY-240223 [H2] You are leaving MAVYRET.com You are leaving the AbbVie website and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility. Conversely, the presence of this link does not imply the linked site's endorsement of MAVYRET.com or AbbVie. Do you wish to leave this site? Yes No US-MAVY-240223 Important Safety Information about MAVYRET including Important Warning on Hepatitis B Reactivation Important Safety Information about MAVYRET including Important Warning on Hepatitis B Reactivation Important Safety Information about MAVYRET including Important Warning on Hepatitis B Reactivation Important Safety Information about MAVYRET including Important Warning on Hepatitis B Reactivation USE MAVYRET is a prescription medicine used to treat adults and children 3 years of age and older with: Acute (recently infected) or chronic (lasting a long time) hepatitis C virus (hep C) genotypes 1, 2, 3, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis. Hep C genotype 1 infection who have been previously treated with a regimen that contained a hep C NS5A inhibitor or an NS3/4A protease inhibitor, but not both. IMPORTANT SAFETY INFORMATION What is the most important information I should know about MAVYRET? Hepatitis B virus (hep B) reactivation: Before starting treatment with MAVYRET, your doctor will do blood tests to check for hep B infection. If you have ever had hep B infection, hep B could become active again during or after treatment for hep C with MAVYRET. Hep B that becomes active again (called reactivation) may cause serious liver problems, including liver failure and death. Your doctor will monitor you if you are at risk for hep B reactivation during treatment and after you stop taking MAVYRET. Do not take MAVYRET if you: Have moderate or severe liver impairment (Child-Pugh B or C) or any history of prior liver decompensation Are taking the medicines atazanavir or rifampin What should I tell my doctor before taking MAVYRET? If you have had hep B infection, have liver problems other than hep C infection, have HIV-1 infection, have had a liver or a kidney transplant, and all other medical conditions. If you are pregnant or plan to become pregnant, or if you are breastfeeding or plan to breastfeed. It is not known if MAVYRET will harm your unborn baby or pass into your breast milk. Talk to your doctor about the best way to feed your baby if you take MAVYRET. About all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. MAVYRET and other medicines may affect each other. This can cause you to have too much or not enough MAVYRET or other medicines in your body. This may affect the way MAVYRET or your other medicines work or may cause side effects. Do not start taking a new medicine without telling your doctor. Your doctor can tell you if it is safe to take MAVYRET with other medicines. What are the possible side effects of MAVYRET? In people who had or have advanced liver problems before starting treatment with MAVYRET, there is a rare risk of worsening liver problems, liver failure, and death. Your doctor will check you for signs and symptoms of worsening liver problems during treatment with MAVYRET. Tell your doctor right away if you have any of the following: nausea; tiredness; yellowing of your skin or white part of your eyes; bleeding or bruising more easily than normal; confusion; dark, black, or bloody stool; loss of appetite; diarrhea; dark or brown (tea-colored) urine; swelling or pain on the upper right side of your stomach area (abdomen); sleepiness; vomiting of blood; or lightheadedness. The most common side effects of MAVYRET are headache and tiredness. These are not all the possible side effects of MAVYRET. Call your doctor for medical advice about side effects. This is the most important information to know about MAVYRET. For more information, talk to your doctor or healthcare provider. MAVYRET oral pellets are dispensed in unit-dose packets. Each pac
15000 chars
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
8Review mentions (all pages)
0External proof links (all pages)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 2 | 0 |
| /locator/ | 2 | 0 |
| /cost/ | 2 | 0 |
| /what-is-mavyret/ | 2 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Homepage schema
{
"@context": "http://schema.org",
"@type": "MedicalWebPage",
"audience": "https://health-lifesci.schema.org/Patient",
"specialty": "http://health-lifesci.schema.org/Gastroenterologic",
"reviewedBy": "AbbVie Inc.",
"url": "https://www.mavyret.com",
"headline": "MAVYRET (glecaprevir/pibrentasvir) for Hepatitis C - Official Site",
"description": "Official MAVYRET (glecaprevir/pibrentasvir) site from AbbVie Inc. for patients. Learn about the use, safety and efficacy of MAVYRET. View full prescribing information.",
"primaryImageOfPage": [
{
"@type": "ImageObject",
"name": "#1 prescribed medicine for chronic hepatitis C (hep C). Have hep C?",
"description": "Hep C: ONLY 8 WEEKS TO CURE",
"url": "https://www.mavyret.com/content/dam/admpmavyret/images/MAVY-ITS-0320/heroes/hero-bg-homepage-large.jpg"
}
],
"potentialaction": [
{
"@type": "ViewAction",
"name": "Why MAVYRET",
"url": "https://www.mavyret.com/what-is-mavyret"
},
{
"@type": "ViewAction",
"name": "Use our locator tool",
"url": "https://www.mavyret.com/locator"
},
{
"@type": "ViewAction",
"name": "Explore real stories of cure",
"url": "https://www.mavyret.com/patient-stories"
},
{
"@type": "ViewAction",
"name": "See how you can save",
"url": "https://www.mavyret.com/cost"
}
],
"about": {
"@type": "Drug",
"name": "MAVYRET",
"nonProprietaryName": "glecaprevir/pibrentasvir",
"description": "MAVYRET is a prescription medicine used to treat adults and children 12 years of age and older or weighing at least 99 pounds (45 kilograms) with chronic (lasting a long time) hepatitis C virus (hep C)",
"administrationRoute": "Oral"
},
"creator": {
"@type": "Corporation",
"name": "AbbVie Inc."
},
"location": {
"@type": "PostalAddress",
"addressLocality": "North Chicago",
"addressRegion": "IL",
"postalCode": "60064"
},
"image": {
"@type": "ImageObject",
"name": "MAVYRET® (glecaprevir/pibrentasvir)",
"contentUrl": "https://www.mavyret.com/content/dam/admpmavyret/images/MAVY-ITS-1208/logos/mavyret-logo.png"
}
}
/locator/
{
"@context": "http://schema.org",
"@type": "MedicalWebPage",
"audience": "https://health-lifesci.schema.org/Patient",
"specialty": "http://health-lifesci.schema.org/Gastroenterologic",
"reviewedBy": "AbbVie Inc.",
"url": "https://www.mavyret.com",
"headline": "MAVYRET (glecaprevir/pibrentasvir) for Hepatitis C - Official Site",
"description": "Official MAVYRET (glecaprevir/pibrentasvir) site from AbbVie Inc. for patients. Learn about the use, safety and efficacy of MAVYRET. View full prescribing information.",
"primaryImageOfPage": [
{
"@type": "ImageObject",
"name": "#1 prescribed medicine for chronic hepatitis C (hep C). Have hep C?",
"description": "Hep C: ONLY 8 WEEKS TO CURE",
"url": "https://www.mavyret.com/content/dam/admpmavyret/images/MAVY-ITS-0320/heroes/hero-bg-homepage-large.jpg"
}
],
"potentialaction": [
{
"@type": "ViewAction",
"name": "Why MAVYRET",
"url": "https://www.mavyret.com/what-is-mavyret"
},
{
"@type": "ViewAction",
"name": "Use our locator tool",
"url": "https://www.mavyret.com/locator"
},
{
"@type": "ViewAction",
"name": "Explore real stories of cure",
"url": "https://www.mavyret.com/patient-stories"
},
{
"@type": "ViewAction",
"name": "See how you can save",
"url": "https://www.mavyret.com/cost"
}
],
"about": {
"@type": "Drug",
"name": "MAVYRET",
"nonProprietaryName": "glecaprevir/pibrentasvir",
"description": "MAVYRET is a prescription medicine used to treat adults and children 12 years of age and older or weighing at least 99 pounds (45 kilograms) with chronic (lasting a long time) hepatitis C virus (hep C)",
"administrationRoute": "Oral"
},
"creator": {
"@type": "Corporation",
"name": "AbbVie Inc."
},
"location": {
"@type": "PostalAddress",
"addressLocality": "North Chicago",
"addressRegion": "IL",
"postalCode": "60064"
},
"image": {
"@type": "ImageObject",
"name": "MAVYRET® (glecaprevir/pibrentasvir)",
"contentUrl": "https://www.mavyret.com/content/dam/admpmavyret/images/MAVY-ITS-1208/logos/mavyret-logo.png"
}
}
/cost/
{
"@context": "http://schema.org",
"@type": "MedicalWebPage",
"audience": "https://health-lifesci.schema.org/Patient",
"specialty": "http://health-lifesci.schema.org/Gastroenterologic",
"reviewedBy": "AbbVie Inc.",
"url": "https://www.mavyret.com",
"headline": "MAVYRET (glecaprevir/pibrentasvir) for Hepatitis C - Official Site",
"description": "Official MAVYRET (glecaprevir/pibrentasvir) site from AbbVie Inc. for patients. Learn about the use, safety and efficacy of MAVYRET. View full prescribing information.",
"primaryImageOfPage": [
{
"@type": "ImageObject",
"name": "#1 prescribed medicine for chronic hepatitis C (hep C). Have hep C?",
"description": "Hep C: ONLY 8 WEEKS TO CURE",
"url": "https://www.mavyret.com/content/dam/admpmavyret/images/MAVY-ITS-0320/heroes/hero-bg-homepage-large.jpg"
}
],
"potentialaction": [
{
"@type": "ViewAction",
"name": "Why MAVYRET",
"url": "https://www.mavyret.com/what-is-mavyret"
},
{
"@type": "ViewAction",
"name": "Use our locator tool",
"url": "https://www.mavyret.com/locator"
},
{
"@type": "ViewAction",
"name": "Explore real stories of cure",
"url": "https://www.mavyret.com/patient-stories"
},
{
"@type": "ViewAction",
"name": "See how you can save",
"url": "https://www.mavyret.com/cost"
}
],
"about": {
"@type": "Drug",
"name": "MAVYRET",
"nonProprietaryName": "glecaprevir/pibrentasvir",
"description": "MAVYRET is a prescription medicine used to treat adults and children 12 years of age and older or weighing at least 99 pounds (45 kilograms) with chronic (lasting a long time) hepatitis C virus (hep C)",
"administrationRoute": "Oral"
},
"creator": {
"@type": "Corporation",
"name": "AbbVie Inc."
},
"location": {
"@type": "PostalAddress",
"addressLocality": "North Chicago",
"addressRegion": "IL",
"postalCode": "60064"
},
"image": {
"@type": "ImageObject",
"name": "MAVYRET® (glecaprevir/pibrentasvir)",
"contentUrl": "https://www.mavyret.com/content/dam/admpmavyret/images/MAVY-ITS-1208/logos/mavyret-logo.png"
}
}
/what-is-mavyret/
{
"@context": "http://schema.org",
"@type": "MedicalWebPage",
"audience": "https://health-lifesci.schema.org/Patient",
"specialty": "http://health-lifesci.schema.org/Gastroenterologic",
"reviewedBy": "AbbVie Inc.",
"url": "https://www.mavyret.com",
"headline": "MAVYRET (glecaprevir/pibrentasvir) for Hepatitis C - Official Site",
"description": "Official MAVYRET (glecaprevir/pibrentasvir) site from AbbVie Inc. for patients. Learn about the use, safety and efficacy of MAVYRET. View full prescribing information.",
"primaryImageOfPage": [
{
"@type": "ImageObject",
"name": "#1 prescribed medicine for chronic hepatitis C (hep C). Have hep C?",
"description": "Hep C: ONLY 8 WEEKS TO CURE",
"url": "https://www.mavyret.com/content/dam/admpmavyret/images/MAVY-ITS-0320/heroes/hero-bg-homepage-large.jpg"
}
],
"potentialaction": [
{
"@type": "ViewAction",
"name": "Why MAVYRET",
"url": "https://www.mavyret.com/what-is-mavyret"
},
{
"@type": "ViewAction",
"name": "Use our locator tool",
"url": "https://www.mavyret.com/locator"
},
{
"@type": "ViewAction",
"name": "Explore real stories of cure",
"url": "https://www.mavyret.com/patient-stories"
},
{
"@type": "ViewAction",
"name": "See how you can save",
"url": "https://www.mavyret.com/cost"
}
],
"about": {
"@type": "Drug",
"name": "MAVYRET",
"nonProprietaryName": "glecaprevir/pibrentasvir",
"description": "MAVYRET is a prescription medicine used to treat adults and children 12 years of age and older or weighing at least 99 pounds (45 kilograms) with chronic (lasting a long time) hepatitis C virus (hep C)",
"administrationRoute": "Oral"
},
"creator": {
"@type": "Corporation",
"name": "AbbVie Inc."
},
"location": {
"@type": "PostalAddress",
"addressLocality": "North Chicago",
"addressRegion": "IL",
"postalCode": "60064"
},
"image": {
"@type": "ImageObject",
"name": "MAVYRET® (glecaprevir/pibrentasvir)",
"contentUrl": "https://www.mavyret.com/content/dam/admpmavyret/images/MAVY-ITS-1208/logos/mavyret-logo.png"
}
}
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Information Density
0 / 30
Read the Narrative & headings: do hard facts (prices, dates, numbers) outweigh fluff power-words?
Semantic Coherence
0 / 20
Compare the homepage promise against the sub-page reality. Do they hold the same line?
Trust & Proof
0 / 20
Weigh review mentions against actual external proof links. Claims without verification = theatre.
Commodity Fingerprint
0 / 15
Check headings & narrative against the industry clichés in the setup above.
Identity & Authority
0 / 15
Inspect the schema: is there real Organization/Person identity with sameAs links, or gaps?
Your predicted BS score
0 / 100
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Information Density
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Semantic Alignment
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Trust & Proof
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Commodity Fingerprint
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Identity & Authority
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
B
BS Level
Medical Devices, Pharma & Biotech
40.7 Avg BS
Based on 784 businesses audited.
✓ Less BS than average
AbbVie Inc. has 28.7 points less BS than the average for Medical Devices, Pharma & Biotech.
BS Detector
Medical Devices, Pharma & Biotech BS: AbbVie Inc. (maviret.com)
https://maviret.com
📍 Industry: Medical Devices, Pharma & Biotech
12
BS / 100
This is a high-substance medical property where legal and clinical requirements force the elimination of bullshit. It effectively uses forensic citations to anchor every significant performance claim.
Info Density
Power-words vs. Substance ratio.
3
10% BS
Semantic Coherence
Homepage promise vs. Sub-page reality.
1
5% BS
Trust & Proof
Verifiable evidence vs. Trust Theatre.
4
20% BS
Commodity Fingerprint
Detection of industry clichés/templates.
2
13% BS
Identity & Authority
Expert verifiability & Schema depth.
2
13% BS
1. Update the patient treatment count footnote, as the 2023 sales data is currently 31 months old (aging). 2. Add outbound links to published clinical trial results on ClinicalTrials.gov to convert footnotes into verified proof paths. 3. Remove or clarify the unverified review_count metadata to prevent it being flagged as trust theatre. 4. Ensure the transcript for the personal message from real patients is indexed to provide further textual evidence of cure claims.
The site is an exact match for the Pharma & Biotech industry, specifically the therapeutic area of Gastroenterology. It adheres to strict regulatory communication standards by balancing efficacy claims with comprehensive Important Safety Information (ISI).
“The low BS score of 12 is driven by the extreme specificity of the clinical claims and the robust schema. Points were only awarded for aging sales data and the technical absence of external proof links in the metadata. The site is almost entirely composed of substance.”
Verified Analysis Date: May 30, 2026
© 1EuroSEO Independent Evaluator — Non-Sponsored Result
Analysis Disclosure & Source Attribution
This training module utilizes a snapshot of public data from AbbVie Inc., captured on May 30, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to AbbVie Inc.: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://maviret.com to view the most current version of its content and learn from the source what this company is about and what it offers.